Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.1536 per EA under NDC 72241001622. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Jul 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241001622
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA208605FDA Approved
7/25/2017
TE Code
AB
On Market Since
2/5/2015
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1536 per EA |
|---|---|
| All-time high | $0.2850 (Dec 13, 2023) |
| All-time low | $0.1274 (Nov 20, 2024) |
| 52-week high | $0.1808 |
| 52-week low | $0.1519 |
| Median price | $0.1803 |
| Average price | $0.1918 |
| Largest weekly change | -33.0% (Nov 20, 2024) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.1536 per EA (NDC 72241001622), effective Aug 19, 2026.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 36.3%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Oct 18, 2023, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1274 (Nov 20, 2024) to a high of $0.2850 (Dec 13, 2023), with a median of $0.1803 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 72241001622) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.